She previously served as Chief Executive Officer at Harpoon Therapeutics until the company’s acquisition by Merck in early 2024 ... scientist at the University Hospital of Dusseldorf in Germany and ...
FRANKFURT, Nov 14 (Reuters) - Merck KGaA (MRCG.DE), opens new tab on Thursday reported a gain of 11.9% in adjusted quarterly ...
The life-sciences and chemical group said it now expects 2024 net sales in the lower half of its previously expected range of ...
(Bloomberg) -- Merck KGaA posted earnings that topped estimates as its ... That’s better than the €1.56 billion average of ...
In a move to safeguard the company’s dominant position in cancer, Merck said Thursday it will license a new cancer drug from ...
2d
Merck KGaA (MKGAY.PK), a German science and technology major, announced that the Phase III MANEUVER trial of pimicotinib, an ...
The life-sciences and chemical group said it now expects 2024 net sales in the lower half of its previously expected range of ...
Hosted on MSN11h
Growth brings higher profits at Germany's MerckDriven by growth across the board, including in its semiconductor business, German science and technology company Merck ...
German sci-tech giant Merck is very optimistic about its prospects in the Chinese market and will continue to strengthen its ...
The PEGylated Proteins Market is primarily driven by the growing demand for effective drug delivery systems, particularly in the treatment of chronic diseases such as cancer, hepatitis, and rheumatoid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback